News
As intended, the nanomedicine inhibited EGFR and IGF-1R signaling and subsequent activation of downstream cell proliferation and survival pathways. The degree of inhibition induced by the nanomedicine ...
Insights into the many facets of cell death, particularly cancer cell evasion mechanisms, are therefore critical to unlock new avenues for treatments. Agilent presents a fully automated, kinetic ...
Key Features and Benefits One of the standout features of ATCC Assay Ready Cells is their consistency. Each batch of cells is produced under stringent quality control measures, ensuring that ...
Multispan has constructed over 1,000 clonal stable cell lines and offers over 1,600 ready-to-use assay tools and reagents. The company’s product portfolio includes stable cell lines, division ...
Background: Breast cancer is the second leading cause of cancer-related mortality among US women, with metastatic breast cancer (MBC) accounting for most deaths. The DefineMBC comprehensive blood ...
As per the deal, ANGLE will develop a methodology for CTC micronuclei detection based on its existing pKAP1 CTC-based DDR assay, which measures expression of a key protein in the DNA damage response.
F and G, BrdU assay (F) and matrix gel culture (G) showed proliferation and tube formation of human aortic endothelial cells (HAECs) were enhanced post-treatment with supernatants from Panx1 siRNA ...
We identified that IGF-1R was a direct target of Y-56 by dual-luciferase reporter assay. Moreover, IGF-1R overexpression promoted the proliferation and cell cycle process of PSCs and upregulated the ...
Don’t miss out on the most exciting applications of cell proliferation today, and find out what still needs to be improved for cell proliferation assays to continue driving drug discovery forward; all ...
Each assay has specific advantages and disadvantages. For example, BrdU assays, a common DNA synthesis cell proliferation analysis method, has the advantage of single-cell resolution, but can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results